Articles
- Patients with Digestive Diseases Gain Hope for Selective Therapies by Targeting Specific Neurotransmitter
- FDA Nod for the First Drug-eluting Stent to Treat Peripheral Arterial Disease
- Nature Method: How to Effectively and Safely Produce Stem Cell
- The Sapien Artificial Heart Valve of Edwards get Extra Indications by FDA
- Turning the Fiction Biotechnology into Reality: Advances in Bio-industry Field
- Two proteins, ATG12 and ATG5 Might Help People Developing Innovative Cancer Therapies
- World Pharma/Clinical Trial Regulatory (From Nov. 29 to Nov. 30)
- Begin to Prepare for the Molecular Diagnostics
- NK Cells & Brain Tumors: Immune cells attack Therapeutic Viruses
- A New Nanotechnology Brings Hope for MS and Other Immune-related Diseases
- Nature: Fighting Alzheimer's Disease from the Perspective of Immune Transmitter
- PLoS ONE: UCP2 Protein Is Important for Natural Born Babies Regarding to Their Subsequent Development
- Worldwide Biotech/Biopharma Alliance (during Nov. 14 and Nov. 12)
- The New Found Genetic Factor-KLF4-is Vital for Cardiovascular Health
- Diagnose Parkinson's disease in Two Minutes
- The Fifth Session of U.S. Pharmacopeial Bioassay Convention
- The Global Trial Site Database Brings into J&J, Merck, Lilly
- The First Meningitis B Vaccine Is Believed to Be Soon Launched in Market
- Can Diabetes Drug be used to treat Brain Cancer?
- Rescue Me from the Peanut Allergy by Inhibiting Pim 1 and Runx3?
- Worldwide Biotech/Biopharma Alliance (From Nov. 12 to Otc. 30, 2012)
- Worldwide Biotech/Biopharma Executives (From Nov. 7 to Nov. 2, 2012)
- Researchers Found a Genetic Reason of Anemia-Atpifl
- The New Diabetes Drug of Novo Nordisk A/S (NVO) Get Approval by FDA